Valuation: Hugel, Inc.

Market Cap 2,02000Cr 147.57Cr 129.8Cr 122.36Cr 111.64Cr 208.78Cr 14TCr 210.4Cr 1.47TCr 569.01Cr 7.21TCr 554.06Cr 542.03Cr 23TCr P/E 2026 *
14x
P/E 2027 * 10.7x
Enterprise Value 148.66Cr 10.86L 10L 9L 8L 15.36L 10Cr 15.48L 1.08Cr 41.87L 5.31Cr 40.77L 39.89L 17Cr EV / Sales 2026 *
2.88x
EV / Sales 2027 * 2.11x
Free-Float
45.22%
Yield 2026 *
-
Yield 2027 * -
1 day-1.79%
1 week-19.05%
Current month-25.79%
1 month-23.67%
3 months-22.73%
6 months-25.20%
Current year-18.87%
1 week 1,85,900
Extreme 185900
2,33,500
1 month 1,85,900
Extreme 185900
2,62,000
Current year 1,85,900
Extreme 185900
3,08,500
1 year 1,85,900
Extreme 185900
3,08,500
3 years 1,19,400
Extreme 119400
3,92,000
5 years 99,700
Extreme 99700
3,92,000
10 years 75,865.91
Extreme 75865.908
3,92,000
Manager TitleAgeSince
Director of Finance/CFO 61 -
Chief Tech/Sci/R&D Officer 54 -
Chief Executive Officer 49 -
Director TitleAgeSince
Director/Board Member 54 29/04/2022
Director/Board Member 56 29/04/2022
Director/Board Member 51 29/04/2022
Date Insider Type Main position Quantity % Market Cap. Importance
20/05/25 Exercice 1,200 0.0095%
20/05/25 Sell 1,200 0.0095%
19/05/25 Exercice

Chairman

31,510 0.2500%
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-19.05%-38.89%+50.44% 147.91Cr
-0.72%+2.76%+40.17%-3.49% 8.01TCr
+6.98%+33.79%+655.41%+94.84% 7.27TCr
-0.07%+2.70%-10.41%-28.96% 6.05TCr
-1.80%-3.05%-14.24%+26.38% 4.62TCr
+0.14%+2.81%+3.67%+158.04% 4.6TCr
-0.51%+4.79%+62.49%-12.15% 3.36TCr
-0.16%-0.25%+47.20%+114.18% 2.53TCr
-3.48%+6.06%+6.80%+166.49% 2.3TCr
-0.82%-0.77%+56.61%+98.36% 1.54TCr
Average -0.24%+2.78%+80.88%+66.41% 4.04TCr
Weighted average by Cap. +0.59%+6.61%+133.64%+52.55%

Financials

2026 *2027 *
Net sales 52TCr 38Cr 33Cr 31Cr 29Cr 53Cr 3.62TCr 54Cr 375.3Cr 145.43Cr 1.84TCr 141.61Cr 138.54Cr 6TCr 64TCr 47Cr 41Cr 39Cr 35Cr 66Cr 4.5TCr 67Cr 466.83Cr 180.9Cr 2.29TCr 176.15Cr 172.33Cr 7.46TCr
Net income 16TCr 12Cr 10Cr 9.84Cr 8.97Cr 17Cr 1.14TCr 17Cr 118.05Cr 46Cr 579.59Cr 45Cr 44Cr 1.89TCr 21TCr 16Cr 14Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 154.38Cr 60Cr 757.98Cr 58Cr 57Cr 2.47TCr
Net Debt -53TCr -39Cr -34Cr -32Cr -29Cr -55Cr -3.74TCr -56Cr -387.85Cr -150.3Cr -1.9TCr -146.35Cr -143.17Cr -6.2TCr -67TCr -49Cr -43Cr -40Cr -37Cr -69Cr -4.66TCr -69Cr -483.4Cr -187.32Cr -2.37TCr -182.4Cr -178.44Cr -7.72TCr
Logo Hugel, Inc.
Hugel Inc is a Korea-based company mainly engaged in the manufacture and sale of biopharmaceutical products. The Company is mainly engaged in the research, development, manufacturing, and sales of biopharmaceuticals utilizing type A botulinum toxin derived from the microorganism clostridium botulinum, as well as hyaluronic acid–based tissue‑restoration biomaterial filler products. In addition, the Company sells botulinum toxin products, hyaluronic acid fillers, cosmetics, skin boosters, and lifting threads. The Company distributes its products in domestic and overseas markets.
Employees
620
Date Price Change Volume
23/26/23 ₩1,87,000.00 -1.79% 42,222
22/26/22 ₩1,90,400.00 -7.57% 2,04,511
21/26/21 ₩2,06,000.00 -3.74% 77,391
18/26/18 ₩2,14,000.00 -7.56% 1,64,420
17/26/17 ₩2,31,500.00 +0.22% 29,436
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,87,000.00KRW
Average target price
3,45,823.53KRW
Spread / Average Target
+84.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A145020 Stock